Back to Search
BROOKE SCHUG, PHARMD
PHARMD
Pharmacist
NPI: 1477935997Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
64301(CA)
Research & Publications (17)
Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chrono-pharmacologically optimized treatment of pain from various sources.
PMID 19473603·Int J Clin Pharmacol Ther·2009
4-observational
[Importance of the formulation for a chronopharmacologically optimised way of pain therapy. Results of a comparative bioavailability study of tramadol extended-release capsules after single-dose evening versus morning administration].
PMID 18540331·MMW Fortschr Med·2008
4-observational
Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
PMID 18343242·Clin Ther·2008
2-rct
Lidocaine 8 mg sore throat lozenges in the treatment of acute pharyngitis. A new therapeutic option investigated in comparison to placebo treatment.
PMID 18193690·Arzneimittelforschung·2007
3-trial
Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects.
PMID 16981901·Br J Clin Pharmacol·2007
2-rct
Pharmacokinetic drug interaction profiles of proton pump inhibitors.
PMID 16944963·Drug Saf·2006
6-review
Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
PMID 16425970·Int J Clin Pharmacol Ther·2006
4-observational
[New guidelines for the assessment of bioavailability and bioequivalence].
PMID 15887065·Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz·2005
4-observational
Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry.
PMID 15639442·J Chromatogr B Analyt Technol Biomed Life Sci·2005
8-other
Pharmacokinetics and bioavailability of denaverine hydrochloride in healthy subjects following intravenous, oral and rectal single doses.
PMID 12594004·Eur J Pharm Sci·2003
3-trial
Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations.
PMID 12495553·J Pharm Pharmacol·2002
3-trial
The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
PMID 12047482·Br J Clin Pharmacol·2002
3-trial
Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast.
PMID 12012144·Eur J Clin Pharmacol·2002
3-trial
Determination of 11-keto-boswellic acid in human plasma.
PMID 12008153·J Pharm Biomed Anal·2002
8-other
Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union.
PMID 11923060·Eur J Pharm Sci·2002
3-trial
Sensitive and specific liquid chromatographic-tandem mass spectrometric assay for dihydroergotamine and its major metabolite in human plasma.
PMID 11888055·J Chromatogr B Analyt Technol Biomed Life Sci·2002
8-other
Simultaneous determination of flupirtine and its major active metabolite in human plasma by liquid chromatography-tandem mass spectrometry.
PMID 11393705·J Chromatogr B Biomed Sci Appl·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1411 E 31ST ST
OAKLAND, CA 94602 - Phone
- (612) 554-0577
Quick Facts
- NPI
- 1477935997
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile